Mml Investors Services, LLC Novo Cure LTD Transaction History

Mml Investors Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$63.98 - $85.37 $21,753 - $29,025	340 Added 11.48%	3,302 $242,000
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $201,386 - $265,306	2,962 New	2,962 $225,000
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $228,211 - $362,476	-4,032 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $35,247 - $49,528	-586 Reduced 12.69%	4,032 $334,000
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $31,833 - $51,723	424 Added 10.11%	4,618 $347,000
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $62,964 - $105,446	542 Added 14.84%	4,194 $487,000
Q2 2021 Aug 13, 2021	BUY	$130.4 - $225.58 $157,262 - $272,049	1,206 Added 49.3%	3,652 $810,000
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $992 - $1,521	-8 Reduced 0.33%	2,446 $323,000
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $275,240 - $427,339	2,454 New	2,454 $425,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Mml Investors Services, LLC with notifications on news.